Health Outcomes Among Patients Diagnosed With Schizophrenia in the Us Veterans Health Administration Population Who Transitioned From Once-Monthly To Once-Every Paliperidone Palmitate: an Observational Retrospective Analysis
| dc.contributor.author | Khouyr, Antoine El | |
| dc.contributor.author | Wang, Li | |
| dc.contributor.author | Joshi, Kruti | |
| dc.contributor.author | Patel, Charmi | |
| dc.contributor.author | Başer, Onur | |
| dc.contributor.author | Huang, Ahong | |
| dc.contributor.author | El Khoury, Antoine | |
| dc.date.accessioned | 2019-08-23T07:41:49Z | |
| dc.date.available | 2019-08-23T07:41:49Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | There is limited literature on treatment patterns, healthcare resource utilization (HRU), and costs among patients who transition from once-monthly paliperidone palmitate (PP1M) to once-every-3-month paliperidone palmitate (PP3M) in a real-world setting. Hence, this study compared treatment patterns, HRU, and costs 12-month pre- and post-PP3M transition among Veteran’s Health Administration (VHA) patients with schizophrenia. | |
| dc.description.sponsorship | This study and the Rapid Service Fee were funded, without restriction, by Janssen Scientific Affairs, LLC, 920 Rte. 202, Raritan, NJ, 08869. All authors had full access to all of the data in this study and take complete responsibility for the integrity of the data and accuracy of the data analysis. Research assistance in the preparation of this article was provided by Jien Li and Catherine Callan of SIMR, LLC, and Richa Bashyal, a former employee of the same. Administrative assistance was provided by Michael Kane of SIMR, LLC. Support for this assistance was funded by Janssen Scientific Affairs, LLC. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. Ahong Huang is an employee of SIMR, LLC, a paid consultant to Janssen Scientific Affairs. Li Wang is an employee of SIMR, LLC, a paid consultant to Janssen Scientific Affairs.Charmi Patel is an employee of Janssen Scientific Affairs and stockholders of Johnson & Johnson. Onur Baser consults for SIMR, LLC. AEK is an employee of Janssen Scientific Affairs and stockholders of Johnson & Johnson. Kruti Joshi is an employee of Janssen Scientific Affairs and stockholders of Johnson & Johnson. Neither institutional review board approval nor consent was necessary for this study, as it was a retrospective analysis conducted with de-identified data; no identifiable patient information or medical records were disclosed for the purposes of this study except in compliance with applicable law. Since the core study did not involve the collection, use, or transmittal of individual identifiable data, the conduct of this study was exempt from institutional review board approval, per the Federal Policy for the Protection of Human Subjects (1991). The datasets generated and analyzed during the current study are included in the published version. | |
| dc.description.sponsorship | Janssen Scientific Affairs | |
| dc.description.sponsorship | Janssen Scientific Affairs; Janssen Scientific Affairs and stockholders of Johnson & Johnson; Janssen Scientific Affairs, LLC; Janssen Scientific Affairs.Charmi Patel; Richa Bashyal; Center for Outcomes Research and Evaluation, Yale School of Medicine, CORE; meet | |
| dc.identifier.citation | Patel, C., El, K. A., Huang, A., Wang, L., Baser, O., & Joshi, K. (August 08, 2019). Health Outcomes Among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis. Advances in Therapy. 1-13. | |
| dc.identifier.doi | 10.1007/s12325-019-01039-9 | |
| dc.identifier.issn | 1865-8652 | |
| dc.identifier.issn | 0741-238X | |
| dc.identifier.scopus | 2-s2.0-85070287900 | |
| dc.identifier.uri | https://doi.org/10.1007/s12325-019-01039-9 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.11779/1129 | |
| dc.language.iso | en | |
| dc.publisher | Springer | |
| dc.relation.ispartof | Advances in Therapy | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Healthcare costs | |
| dc.subject | Schizophrenia | |
| dc.subject | Medication adherence | |
| dc.subject | Antipsychotic agents | |
| dc.subject | Neurology | |
| dc.subject | Paliperidone palmitate | |
| dc.title | Health Outcomes Among Patients Diagnosed With Schizophrenia in the Us Veterans Health Administration Population Who Transitioned From Once-Monthly To Once-Every Paliperidone Palmitate: an Observational Retrospective Analysis | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Başer, Onur | |
| gdc.author.scopusid | 6507336249 | |
| gdc.author.scopusid | 56693895000 | |
| gdc.author.scopusid | 57190248861 | |
| gdc.author.scopusid | 8712851500 | |
| gdc.author.scopusid | 57204664831 | |
| gdc.author.scopusid | 57201067389 | |
| gdc.author.wosid | Baser, Onur/PGA-2243-2026 | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C4 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | true | |
| gdc.description.department | İİSBF, Ekonomi Bölümü | |
| gdc.description.departmenttemp | [Patel, Charmi; El Khoury, Antoine; Joshi, Kruti] Janssen Sci Affairs LLC, 920 Rte 202, Raritan, NJ 08869 USA; [Huang, Ahong; Wang, Li] STATinMED, 5340 Legacy Dr,Suite 175, Plano, TX 75024 USA; [Baser, Onur] MEF Univ, Dept Econ, Leylak Sk 22, TR-34340 Istanbul, Turkey | |
| gdc.description.endpage | 13 | |
| gdc.description.issue | 10 | |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | 1 | |
| gdc.description.volume | 36 | |
| gdc.description.woscitationindex | Science Citation Index Expanded - Social Science Citation Index | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W2967690180 | |
| gdc.identifier.pmid | 31396809 | |
| gdc.identifier.wos | WOS:000488950000028 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.accesstype | HYBRID | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 5.0 | |
| gdc.oaire.influence | 4.042827E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.keywords | Adult | |
| gdc.oaire.keywords | Aged, 80 and over | |
| gdc.oaire.keywords | Male | |
| gdc.oaire.keywords | Administration, Oral | |
| gdc.oaire.keywords | Veterans Health | |
| gdc.oaire.keywords | Middle Aged | |
| gdc.oaire.keywords | Patient Acceptance of Health Care | |
| gdc.oaire.keywords | Drug Administration Schedule | |
| gdc.oaire.keywords | United States | |
| gdc.oaire.keywords | Patient Outcome Assessment | |
| gdc.oaire.keywords | Young Adult | |
| gdc.oaire.keywords | Paliperidone Palmitate | |
| gdc.oaire.keywords | Schizophrenia | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Female | |
| gdc.oaire.keywords | Longitudinal Studies | |
| gdc.oaire.keywords | Aged | |
| gdc.oaire.keywords | Antipsychotic Agents | |
| gdc.oaire.keywords | Retrospective Studies | |
| gdc.oaire.keywords | Veterans | |
| gdc.oaire.popularity | 5.4902376E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 0.9847 | |
| gdc.openalex.normalizedpercentile | 0.75 | |
| gdc.opencitations.count | 6 | |
| gdc.plumx.crossrefcites | 1 | |
| gdc.plumx.mendeley | 40 | |
| gdc.plumx.pubmedcites | 4 | |
| gdc.plumx.scopuscites | 5 | |
| gdc.publishedmonth | Mayıs | |
| gdc.scopus.citedcount | 5 | |
| gdc.virtual.author | Başer, Onur | |
| gdc.wos.citedcount | 5 | |
| gdc.wos.collaboration | Uluslararası işbirliği ile yapılan - EVET | |
| gdc.wos.documenttype | Article | |
| gdc.wos.indexdate | 2019 | |
| gdc.wos.publishedmonth | Ağustos | |
| gdc.yokperiod | YÖK - 2018-19 | |
| relation.isAuthorOfPublication | 6960b0ec-7a84-4e87-a091-3b9e22c72a9c | |
| relation.isAuthorOfPublication.latestForDiscovery | 6960b0ec-7a84-4e87-a091-3b9e22c72a9c | |
| relation.isOrgUnitOfPublication | 5664fa6c-ff72-48d2-8431-5b401dcf7a5f | |
| relation.isOrgUnitOfPublication | a6e60d5c-b0c7-474a-b49b-284dc710c078 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 5664fa6c-ff72-48d2-8431-5b401dcf7a5f |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Health-Outcomes-Among-Patients-Diagnosed-with-Schizophrenia-in-the-US-Veterans-Health-Administration-Population-Who-Transitioned-from-OnceMonthly-to-OnceEvery3Month-Paliperidone-Palmitate-An-Observational-R.pdf
- Size:
- 368.57 KB
- Format:
- Adobe Portable Document Format
- Description:
- Yayıncı Sürümü - Makale
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.44 KB
- Format:
- Item-specific license agreed upon to submission
- Description: